Zelira Therapeutics / HOPE 1 SPV
Cornerstone investment via TGC Biotechnology Fund.
Proprietary capital · Public & private markets
ThirdGate invests its own capital across structures, asset classes, sectors and geographies, without the horizon constraints of traditional funds.
Our Approach →Firm overview
ThirdGate Capital Global Management, LLC, together with its affiliated funds and companies, is a proprietary investment firm investing across capital structures, asset classes, industry sectors and geographies in public and private markets to generate superior risk-adjusted returns and create long-term value for our partners.
Figures as of [date]. Figures are the firm's representations and are subject to verification.
How we think
We view every opportunity with a long-term perspective, deploying proprietary capital to support and grow our portfolio without traditional constraints or fixed investment horizons.
Read more →Our collaborative approach extends across sectors, regions and strategies, unlocking synergies between portfolio businesses and driving differentiated performance.
Read more →Knowledge, experience and relationships that make deals more creative and profitable, and the ingenuity to structure transactions that otherwise wouldn't happen.
Read more →Seamless communication across a global investment team, with offices in New York, Kenya, London, Mauritius, Singapore and Switzerland.
Read more →What we do
Growth and control positions, from early-stage ventures to established companies.
Explore→Direct and structured investments in commercial, residential and mixed-use property.
Explore→Liquid public-market strategies held alongside our private positions.
Explore→Long-life assets in energy, transport and digital infrastructure.
Explore→Natural resources, agriculture and other tangible assets with durable cash flows.
Explore→Global presence
Select investments
Cornerstone investment via TGC Biotechnology Fund.
Representative investments only; inclusion does not imply performance.